Trials / Completed
CompletedNCT01595828
Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome
An Open Label Study of the Chronic and Acute Effects of Pitavastatin on Monocyte Phenotype, Endothelial Dysfunction and HDL Atheroprotective Function in Subjects With Metabolic Syndrome (CAPITAIN)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Kowa Research Europe · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine in detail the acute and chronic effects of pitavastatin on plasma lipid transport and atheroma biomarkers in patients at elevated risk for the premature development of atherosclerosis (CAPITAIN).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pitavastatin |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-05-10
- Last updated
- 2013-07-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01595828. Inclusion in this directory is not an endorsement.